Empire Pharmacy Inc. and Skyline Pharmacy Inc.
Outcome
DEA issued Order to Show Cause and Immediate Suspension to both Philadelphia pharmacies October 31, 2023; revoked DEA Certificates of Registration Nos. FE8167733 and FS0903840 effective May 16, 2025, for controlled substance dispensing practices inconsistent with the public interest.
Details
Empire Pharmacy Inc. and Skyline Pharmacy Inc. — DEA Immediate Suspension and Revocation (2023–2025)
Outcome: DEA issued an Order to Show Cause and Immediate Suspension of Registrations to both Empire Pharmacy, Inc. and Skyline Pharmacy, Inc. of Philadelphia, Pennsylvania on October 31, 2023; DEA Acting Administrator Derek Maltz signed the revocation order on April 10, 2025, revoking DEA Certificates of Registration Nos. FE8167733 and FS0903840 effective May 16, 2025.
On October 31, 2023, the Drug Enforcement Administration issued simultaneous Orders to Show Cause and Immediate Suspension of Registrations to Empire Pharmacy, Inc. and Skyline Pharmacy, Inc. of Philadelphia, Pennsylvania — on the same date that four other Philadelphia-area pharmacies (Liberty, Metro Care, RiteCare, United Pharmacy Upper Darby) also received OSC/ISOs, suggesting a coordinated enforcement action targeting a network of related pharmacies in the Philadelphia area.
The OSC proposed revocation of both pharmacies' DEA registrations, alleging that their continued registration was inconsistent with the public interest under 21 U.S.C. § 824(a)(4). DEA Acting Administrator Derek Maltz signed the final Decision and Order on April 10, 2025. The DEA revoked DEA Certificates of Registration Nos. FE8167733 (Empire) and FS0903840 (Skyline) and denied any pending renewal or modification applications, as well as any pending applications for additional DEA registration in Pennsylvania. The order became effective May 16, 2025. The Decision and Order was published in the Federal Register on April 16, 2025.
Primary Source: Empire Pharmacy Inc.; Skyline Pharmacy Inc.; Decision and Order (Fed. Reg. Apr. 16, 2025)
How Crucible Prevents This
Empire and Skyline were simultaneously targeted on the same date as four other Philadelphia-area pharmacies (Liberty, Metro Care, RiteCare, United) — suggesting a coordinated network of non-compliant pharmacies. Crucible's network-level outlier detection, identifying clusters of pharmacies with shared ownership, supply chains, or patient populations exhibiting diversion patterns, would have flagged this group-level risk.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works